Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Wednesday, September 9, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings. (via Science Daily)
Read the Full StoryThis article will expire in 28 days.
In the News...
View All Recent News
- Caffeine may flip an ancient cellular switch linked to slower aging
- Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
- Scientists find a bone-building switch that could fight osteoporosis
- Early statin use linked to 15% lower dementia risk
- MIT scientists develop injectable “mini livers” that work inside the body
- Scientists find a new weakness in treatment-resistant prostate cancer
- Your gut microbiome may be more contagious than scientists thought
- Cialis linked to higher glaucoma risk in large study
- Scientists discover a hidden immune signal that helps spinal cords regrow
- Scientists say love follows hidden mathematical rules
- Cancer cases could surge 67% worldwide by 2050
- Common dry-cleaning chemical linked to triple the risk of liver scarring
- Scientists observe Einstein’s gravity in the quantum world for the first time
- Your personality may be more genetic than scientists realized
- Ozempic and Wegovy may have an unexpected mental health benefit
- Scientists discover a powerful new antivenom hidden in rattlesnake blood
- This lifestyle program improved cognition 55% more than basic health advice
- Scientists discover a hidden problem with this popular sugar substitute
- Scientists find breast cancer cells hiding behind protective “shields”
- Popular brain supplement linked to shorter lifespan in men